The Europe Blood Plasma Derivatives Market would witness market growth of 9.1% CAGR during the forecast period (2022-2028).
Plasma, or blood plasma, is the liquid component of blood. Plasma functions as a transport medium for providing nutrients to the cells of the different organs of the body and for transferring metabolic waste products to the liver, kidneys, and lungs for elimination. It is also a blood cell transport mechanism and plays a crucial function in maintaining appropriate blood pressure.
Plasma helps maintain homeostasis, also called biological stability, including the acid-base balance within the blood and organism. Blood cells, including white blood cells (leukocytes), red blood cells (erythrocytes), and platelets (thrombocytes), are isolated from whole blood to produce plasma. The residual straw-colored fluid comprises a significant amount of water, but it also includes essential solutes required for life. Electrolytes, like sodium, potassium, magnesium, bicarbonate, and calcium are important ingredients.
In addition, traces of amino acids, organic acids, vitamins, pigments, and enzymes are present. The endocrine system secretes hormones such as corticosteroids, insulin, and thyroxine into the blood. Hormone plasma concentrations must be carefully managed for optimal health. With renal failure, the amount of nitrogenous wastes (such as urea and creatinine) delivered to the kidney for excretion increases significantly.
The increasing government, as well as international support in the European countries in order to improve plasma research and uses, would accelerate the growth of the blood plasma derivatives market in the region. FDA has MRAs in place with the European Union and the United Kingdom. Since 2014, the FDA and the EU have partnered to study how each authority inspects drug producers and the risks and advantages of mutual recognition of drug inspections. The increasing focus of government along with various public organizations would drive the growth of the regional market.
The Germany market dominated the Europe Blood Plasma Derivatives Market by Country in 2021; thereby, achieving a market value of $4,815.1 Million by 2028. The UK market is exhibiting a CAGR of 8.2% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 9.9% during (2022 - 2028).
Based on Application, the market is segmented into Immunodeficiency Diseases, Hypogammaglobulinemia, Hemophilia, Von Willebrand's Disease, and Others. Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Blood Plasma Derivatives Market will Hit $72.5 Billion by 2028, at a CAGR of 9.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Takeda Pharmaceutical Company Limited, Grifols, S.A., Biotest AG, LFB S.A., CSL Limited, Octapharma AG, Kedrion S.p.A, Sanofi S.A. and Fusion Health Care Pvt. Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Immunodeficiency Diseases
- Hypogammaglobulinemia
- Hemophilia
- Von Willebrand's Disease
- Others
By End User
By Type
- Immunoglobulin
- Albumin
- Factor VIII
- Factor IX
- Hyperimmune Globulin
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Bayer AG
- Takeda Pharmaceutical Company Limited
- Grifols, S.A.
- Biotest AG
- LFB S.A.
- CSL Limited
- Octapharma AG
- Kedrion S.p.A
- Sanofi S.A.
- Fusion Health Care Pvt. Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Blood Plasma Derivatives Market, by Application
1.4.2 Europe Blood Plasma Derivatives Market, by End User
1.4.3 Europe Blood Plasma Derivatives Market, by Type
1.4.4 Europe Blood Plasma Derivatives Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Blood Plasma Derivatives Market
Chapter 4. Europe Blood Plasma Derivatives Market by Application
4.1 Europe Immunodeficiency Diseases Market by Country
4.2 Europe Hypogammaglobulinemia Market by Country
4.3 Europe Hemophilia Market by Country
4.4 Europe Von Willebrand's Disease Market by Country
4.5 Europe Others Market by Country
Chapter 5. Europe Blood Plasma Derivatives Market by End User
5.1 Europe Hospitals Market by Country
5.2 Europe Clinics Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Blood Plasma Derivatives Market by Type
6.1 Europe Immunoglobulin Market by Country
6.2 Europe Albumin Market by Country
6.3 Europe Factor VIII Market by Country
6.4 Europe Factor IX Market by Country
6.5 Europe Hyperimmune Globulin Market by Country
6.6 Europe Others Market by Country
Chapter 7. Europe Blood Plasma Derivatives Market by Country
7.1 Germany Blood Plasma Derivatives Market
7.1.1 Germany Blood Plasma Derivatives Market by Application
7.1.2 Germany Blood Plasma Derivatives Market by End User
7.1.3 Germany Blood Plasma Derivatives Market by Type
7.2 UK Blood Plasma Derivatives Market
7.2.1 UK Blood Plasma Derivatives Market by Application
7.2.2 UK Blood Plasma Derivatives Market by End User
7.2.3 UK Blood Plasma Derivatives Market by Type
7.3 France Blood Plasma Derivatives Market
7.3.1 France Blood Plasma Derivatives Market by Application
7.3.2 France Blood Plasma Derivatives Market by End User
7.3.3 France Blood Plasma Derivatives Market by Type
7.4 Russia Blood Plasma Derivatives Market
7.4.1 Russia Blood Plasma Derivatives Market by Application
7.4.2 Russia Blood Plasma Derivatives Market by End User
7.4.3 Russia Blood Plasma Derivatives Market by Type
7.5 Spain Blood Plasma Derivatives Market
7.5.1 Spain Blood Plasma Derivatives Market by Application
7.5.2 Spain Blood Plasma Derivatives Market by End User
7.5.3 Spain Blood Plasma Derivatives Market by Type
7.6 Italy Blood Plasma Derivatives Market
7.6.1 Italy Blood Plasma Derivatives Market by Application
7.6.2 Italy Blood Plasma Derivatives Market by End User
7.6.3 Italy Blood Plasma Derivatives Market by Type
7.7 Rest of Europe Blood Plasma Derivatives Market
7.7.1 Rest of Europe Blood Plasma Derivatives Market by Application
7.7.2 Rest of Europe Blood Plasma Derivatives Market by End User
7.7.3 Rest of Europe Blood Plasma Derivatives Market by Type
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Grifols, S.A
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Biotest AG (Tiancheng International Investment Limited)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.5 LFB S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 CSL Limited (CSL Behring)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Octapharma AG
8.7.1 Company Overview
8.8 Kedrion S.p.A
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Product Launches and Product Expansions:
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Fusion Health Care Pvt. Ltd.
8.10.1 Company Overview
TABLE 1 Europe Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 2 Europe Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 3 Europe Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 4 Europe Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 5 Europe Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Von Willebrand's Disease Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Von Willebrand's Disease Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 16 Europe Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 17 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Clinics Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Clinics Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 24 Europe Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 25 Europe Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Albumin Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Albumin Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Factor VIII Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Factor VIII Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Factor IX Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Factor IX Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Hyperimmune Globulin Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Hyperimmune Globulin Market by Country, 2022 - 2028, USD Million
TABLE 35 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 36 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 37 Europe Blood Plasma Derivatives Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Blood Plasma Derivatives Market by Country, 2022 - 2028, USD Million
TABLE 39 Germany Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 40 Germany Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 41 Germany Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 42 Germany Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 43 Germany Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 44 Germany Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 45 Germany Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 46 Germany Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 47 UK Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 48 UK Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 49 UK Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 50 UK Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 51 UK Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 52 UK Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 53 UK Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 54 UK Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 55 France Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 56 France Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 57 France Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 58 France Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 59 France Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 60 France Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 61 France Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 62 France Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 63 Russia Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 64 Russia Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 65 Russia Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 66 Russia Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 67 Russia Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 68 Russia Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 69 Russia Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 70 Russia Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 71 Spain Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 72 Spain Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 73 Spain Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 74 Spain Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 75 Spain Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 76 Spain Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 77 Spain Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 78 Spain Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 79 Italy Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 80 Italy Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 81 Italy Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 82 Italy Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 83 Italy Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 84 Italy Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 85 Italy Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 86 Italy Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 87 Rest of Europe Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 88 Rest of Europe Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 89 Rest of Europe Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 90 Rest of Europe Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 91 Rest of Europe Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 92 Rest of Europe Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 93 Rest of Europe Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 94 Rest of Europe Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 95 Key Information – Bayer AG
TABLE 96 Key Information – Takeda Pharmaceutical Company Limited
TABLE 97 Key information – Grifols, S.A.
TABLE 98 key information – Biotest AG
TABLE 99 Key Information – LFB S.A
TABLE 100 key Information – CSL Limited
TABLE 101 Key Information – Octapharma AG
TABLE 102 key Information – Kedrion S.p.A
TABLE 103 Key Information – Sanofi S.A.
TABLE 104 Key Information – Fusion Health Care Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Grifols, S.A.
FIG 3 Recent strategies and developments: Kedrion S.p.A